UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
NUGGET EXPLORATION, INC.
------------------------
(Name of Issuer)
COMMON STOCK, PAR VALUE $0.01
-----------------------------
(Title of Class of Securities)
669903304
---------
(CUSIP Number)
DR. LEONARD VERNON, 2051 SPRINGDALE ROAD, CHERRY HILL, NEW JERSEY 08003,
800-204-1902
-------------------------------------------------------------------------------
(Name, address and telephone number of person
authorized to receive notices and communications)
NOVEMBER 10, 1999
-----------------
(Date of Event which Requires Filing of This Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box ( ).
Check the following box if a fee is being paid with the statement ( )
Page 1 of 9
1
<PAGE>
SCHEDULE 13D
CUSIP NO. 669903304 PAGE 2 OF 9
- --------------------------------------------------------------------------------
1) NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
William D. Hanna
- --------------------------------------------------------------------------------
2) CHECK THE APPROPRIATE BOX IF EITHER IS A MEMBER OF A GROUP (A) ( )
(B) ( )
- --------------------------------------------------------------------------------
3) SEC USE ONLY
- --------------------------------------------------------------------------------
4) SOURCE OF FUNDS
OO
- --------------------------------------------------------------------------------
5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(D) OR 2(E). [ ]
- --------------------------------------------------------------------------------
6) CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.
- --------------------------------------------------------------------------------
NUMBER OF 7) SOLE VOTING POWER 500,000
SHARES
BENEFICIALLY 8) SHARED VOTING POWER 0
OWNED BY
EACH 9) SOLE DISPOSITIVE POWER 500,000
REPORTING
PERSON WITH 10) SHARED DISPOSITIVE POWER 0
- --------------------------------------------------------------------------------
11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
500,000
- --------------------------------------------------------------------------------
12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES
( )
- --------------------------------------------------------------------------------
13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
12.2%
- --------------------------------------------------------------------------------
14) TYPE OF REPORTING PERSON
IN
2
<PAGE>
SCHEDULE 13D
CUSIP NO. 669903304 PAGE 3 OF 9
- -------------------------------------------------------------------------------
1) NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Kevin O'Donnell
- --------------------------------------------------------------------------------
2) CHECK THE APPROPRIATE BOX IF EITHER IS A MEMBER OF A GROUP (A) ( )
(B) ( )
- --------------------------------------------------------------------------------
3) SEC USE ONLY
- --------------------------------------------------------------------------------
4) SOURCE OF FUNDS
OO
- --------------------------------------------------------------------------------
5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(D) OR 2(E). [ ]
- --------------------------------------------------------------------------------
6) CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.
- --------------------------------------------------------------------------------
NUMBER OF 7) SOLE VOTING POWER 500,000
SHARES
BENEFICIALLY 8) SHARED VOTING POWER 0
OWNED BY
EACH 9) SOLE DISPOSITIVE POWER 500,000
REPORTING
PERSON WITH 10) SHARED DISPOSITIVE POWER 0
- --------------------------------------------------------------------------------
11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
500,000
- --------------------------------------------------------------------------------
12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES
( )
- --------------------------------------------------------------------------------
13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
12.2%
- --------------------------------------------------------------------------------
14) TYPE OF REPORTING PERSON
IN
3
<PAGE>
SCHEDULE 13D
CUSIP NO. 669903304 PAGE 4 OF 9
- --------------------------------------------------------------------------------
1) NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Sandra Vernon
- --------------------------------------------------------------------------------
2) CHECK THE APPROPRIATE BOX IF EITHER IS A MEMBER OF A GROUP (A) ( )
(B) ( )
- --------------------------------------------------------------------------------
3) SEC USE ONLY
- --------------------------------------------------------------------------------
4) SOURCE OF FUNDS
OO
- --------------------------------------------------------------------------------
5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(D) OR 2(E). [ ]
- --------------------------------------------------------------------------------
6) CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.
- --------------------------------------------------------------------------------
NUMBER OF 7) SOLE VOTING POWER 2,000,000
SHARES
BENEFICIALLY 8) SHARED VOTING POWER 0
OWNED BY
EACH 9) SOLE DISPOSITIVE POWER 2,000,000
REPORTING
PERSON WITH 10) SHARED DISPOSITIVE POWER 0
- --------------------------------------------------------------------------------
11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,000,000
- --------------------------------------------------------------------------------
12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES
( )
- --------------------------------------------------------------------------------
13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
48.8%
- --------------------------------------------------------------------------------
14) TYPE OF REPORTING PERSON
IN
4
<PAGE>
SCHEDULE 13D
CUSIP NO. 669903304 PAGE 5 OF 9
- --------------------------------------------------------------------------------
1) NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Dr. Leonard Vernon
- --------------------------------------------------------------------------------
2) CHECK THE APPROPRIATE BOX IF EITHER IS A MEMBER OF A GROUP (A) ( )
(B) (X)
- --------------------------------------------------------------------------------
3) SEC USE ONLY
- --------------------------------------------------------------------------------
4) SOURCE OF FUNDS
OO
- --------------------------------------------------------------------------------
5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(D) OR 2(E). [ ]
- --------------------------------------------------------------------------------
6) CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.
- --------------------------------------------------------------------------------
NUMBER OF 7) SOLE VOTING POWER 0
SHARES
BENEFICIALLY 8) SHARED VOTING POWER 2,000,000
OWNED BY
EACH 9) SOLE DISPOSITIVE POWER 0
REPORTING
PERSON WITH 10) SHARED DISPOSITIVE POWER 2,000,000
- --------------------------------------------------------------------------------
11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
- --------------------------------------------------------------------------------
12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES
( X )
- --------------------------------------------------------------------------------
13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
- ----------------------------------------------------------
14) TYPE OF REPORTING PERSON
IN
5
<PAGE>
ITEM 1. SECURITY AND ISSUER
This statement relates to common stock, par value $0.01 ("Common Stock"), of
Nugget Exploration, Inc., a Nevada corporation with principal executive offices
at 2051 Springdale Road, Cherry Hill, New Jersey 08003 (the "Company").
ITEM 2. IDENTITY AND BACKGROUND
This statement is filed jointly by William D. Hanna, Kevin O'Donnell, Sandra
Vernon and Dr. Leonard Vernon. William D. Hanna is a citizen of the United
States whose principal occupation is as an entrepreneur in the medical equipment
industry and whose business address is 2051 Springdale Road, Cherry Hill, New
Jersey 08003. Kevin O'Donnell is a citizen of the United States principally
occupied as an marketing and sales entrepreneur from the address of 2051
Springdale Road, Cherry Hill, New Jersey 08003. Dr. Leonard Vernon and Sandra
Vernon are husband and wife and citizens of the United States. The business
address of both Dr. Leonard Vernon and Sandra Vernon is 2051 Springdale Road,
Cherry Hill, New Jersey 08003. Dr. Leonard Vernon's principal occupation is a
chiropractor, while Sandra Vernon is principally occupied as an investor.
None of the individuals described above have, during the last five years, been
(a) convicted in a criminal proceeding (excluding traffic violations or similar
misdemeanors), or (b) a party to a civil proceeding of a judicial or
administrative body of competent jurisdiction as a result of which proceeding
any of the above was or is subject to a judgment, decree or final order
enjoining future violations of, or prohibiting or mandating activities subject
to, or finding any violation with respect to federal or state securities laws.
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
William D. Hanna, Kevin O'Donnell, Sandra Vernon and Dr. Leonard Vernon (the
"Shareholders") acquired all shares described in this Schedule 13D when the
Company acquired GoHealth.MD Inc.("GoHealth"), a Delaware corporation in which
the Shareholders possessed material ownership.
The Shareholders received shares of Common Stock when the Company's wholly owned
subsidiary, Nugget Holding Company, a Delaware corporation ("Newco"), merged
with and into GoHealth, pursuant to a Stock Exchange Agreement and Plan of
Merger ("Merger"), dated September 30, 1999 ("Merger Agreement"). GoHealth
survived the Merger and became a wholly owned subsidiary of the Company.
Pursuant to the terms of the Merger Agreement, each of the 3,102,000 outstanding
shares of GoHealth's common stock, par value $0.001 (the "GoHealth Stock"), was
converted into and exchanged for one share of the Company's common stock, par
value $0.01 (the "Company's Common Stock"). Therefore, the Shareholders received
a quantity of shares of the Company's Common Stock equal to that quantity of
shares each owned in GoHealth prior to the Merger.
6
<PAGE>
ITEM 4. PURPOSE OF TRANSACTION
The purpose of the transaction was to effect the Merger, which is more fully
described in Item 3 above, of GoHealth with and into Newco, whereby GoHealth
became a wholly owned subsidiary of the Company.
Immediately subsequent to the Merger, all previous shareholders of GoHealth
voted to change the Company's name to "GoHealth.MD Inc." by written consent in
lieu of a meeting. On December 30, 1999, the Company expects to send an
Information Statement pursuant to Section 14(c) of the Securities Exchange Act
1934 to all of the Company's shareholders of record as of December 1, 1999. The
name change shall be effective twenty (20) calendar days after this Information
Statement is mailed to the Company's shareholders, which would thus be January
20, 2000.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER
The aggregate number and percentage of class of securities identified pursuant
to Item 1 beneficially owned by each person named in Item 2 may be found in rows
11 and 13 of the cover pages. The powers each person identified in the preceding
paragraph have relative to the shares discussed herein may be found in rows 7
through 10 of the cover page. With the exception of Dr. Leonard Vernon, only the
reporting persons listed herein have the right to receive or power to direct the
receipt of dividends from, or the proceeds from the sale of, such securities.
Dr. Leonard Vernon is deemed to beneficially own the shares listed in the name
of his wife, Sandra Vernon, as identified herein. Dr.
Vernon expressly disclaims any beneficial ownership of such shares.
A description of all transactions in the Common Stock effected by all persons
named herein is found in Item 3 above.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO
SECURITIES OF THE ISSUER.
Not Applicable.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS.
Attached as Exhibit A is a copy of an agreement between and among William D.
Hanna, Kevin O'Donnell, Sandra Vernon and Dr. Leonard Vernon whereby they
consent to have this statement filed on their behalf pursuant to Rule 13d-1(f)
of the Securities Exchange Act of 1934.
The September 30, 1999 Stock Exchange Agreement and Plan of Merger referred to
in Item 4 above, is incorporated herein by reference from the Company's Form
10-QSB for the quarter ended August 30, 1999.
7
<PAGE>
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
William D. Hanna
/S/ WILLIAM D. HANNA DATE: 12/20/99
- ----------------------
William D. Hanna
Kevin O'Donnell
/S/ KEVIN O'DONNELL DATE: 12/20/99
- ----------------------
Kevin O'Donnell
Sandra Vernon
/S/ SANDRA VERNON DATE: 12/20/99
- ----------------------
Sandra Vernon
Dr. Leonard Vernon
/S/ DR. LEONARD VERNON DATE: 12/20/99
- ----------------------
Dr. Leonard Vernon
8
Exhibit A
JOINT FILING AGREEMENT
THIS JOINT FILING AGREEMENT ("Agreement") is entered into between and among
William D. Hanna ("WH"), Kevin O'Donnell ("KO"), Sandra Vernon ("SV") and Dr.
Leonard Vernon
("LV") ON THIS 16TH day of December 1999.
NOW, THEREFORE, based on the foregoing premises, which are incorporated
herein by this reference, and for and in consideration of the mutual covenants
and agreements contained herein, and in reliance on the representations and
warranties set forth in this Agreement, the benefits to be derived herein and
for other valuable consideration, the sufficiency of which is hereby expressly
acknowledged, the Parties agree as follows:
1. WH, KO, SV and LV acknowledge that all are required to file with the
Securities and Exchange Commission a Schedule 13D as a result of their
individual acquisitions of common stock in Nugget Exploration, Inc. and, in
the interest of consolidation and efficiency, desire to file a single
statement pursuant to Rule 13d-1(f) of the Securities Exchange Act of 1934.
2. WH, KO, SV and LV hereby consent to have a single Schedule 13D filed
pursuant to Rule 13d- 1(f) as fulfillment of the individual obligation of
WH, the individual obligation of KO, the individual obligation of SV, and
the individual obligation of LV to file such a schedule in a joint manner.
IN WITNESS WHEREOF, the signatures of the parties hereto evidence their
mutual assent and acceptance of this Agreement as of the date first set forth
above.
"WH" -William D. Hanna
/S/ WILLIAM D. HANNA
- -----------------------
William D. Hanna
"KO" - Kevin O'Donnell
/S/ KEVIN O'DONNELL
- -----------------------
Kevin O'Donnell
"SV" - Sandra Vernon
/S/ SANDRA VERNON
- -----------------------
Sandra Vernon
"LV" - Dr. Leonard Vernon
/S/ DR. LEONARD VERNON
- -----------------------
Dr. Leonard Vernon
9
